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Abstract
Background: Complementary and alternative medical (CAM) therapies are commonly used by
pediatric patients with chronic medical conditions. Little is known about parents' perceptions of
these therapies. This study describes the views of parents of patients with juvenile idiopathic
arthritis (JIA) regarding conventional and CAM therapies.
Methods: Parents of children with JIA seen at a pediatric rheumatology clinic were surveyed
between June 1 and July 31, 2007. Questionnaires asked about patients' use of over 75 therapies in
the past 30 days, their perceived helpfulness (0 = not helpful; 3 = very helpful), perceived side
effects (0 = none; 3 = severe), and whether each therapy would be recommended to other patients
with JIA (Yes, No, Not sure).
Results: Questionnaires were returned by 52/76 (68%) parents; patients' average age was 10.9
years and 87% were Caucasian. Medications were used by 45 (88%) patients; heat (67%) and extra
rest (54%) were also commonly used. CAM therapies were used by 48 (92%), e.g., massage (54%),
vitamins and other supplements (54%), avoiding foods that worsened pain (35%) and stress
management techniques (33%). Among the therapies rated by 3 or more parents, those that scored
2.5 or higher on helpfulness were: biologic medications, methotrexate, naproxen, wheelchairs,
orthotics, heat, vitamins C and D, music, support groups and prayer. CAM therapies had 0 median
side effects and parents would recommend many of them to other families.
Conclusion: JIA patients use diverse therapies. Parents report that many CAM therapies are
helpful and would recommend them to other parents. These data can be used in counseling patients
and guiding future research.
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Background
Juvenile Idiopathic Arthritis (JIA), is the most common
arthropathy of childhood with an estimated prevalence of
7 to 400/100,000 children [1]. Pharmacologic therapy tra-
ditionally involves the use of non-steroidal anti-inflam-
matory drugs (NSAIDs); modern therapy also includes
disease-modifying agents, including biologic agents,
methotrexate, sulfasalazine and corticosteroids. Physical
and occupational therapy are integral to maintain mobil-
ity and adapt to daily living. Extra rest as well as heat and
exercise are also commonly recommended to help reduce
symptoms.
Complementary and alternative medical (CAM) therapy
has been variously defined as including dietary supple-
ments, dietary modifications, stress management, prayer,
massage, acupuncture, homeopathy, and home or folk
remedies such as dietary changes, liniments and copper
bracelets [2]. As reported in previous studies, patients with
chronic pain, such as those with JIA use CAM therapies
[3,4]. For example, 64% of pediatric rheumatology
patients in Toronto reported using CAM, most often vita-
mins, minerals, and relaxation techniques [5]. Most
(70%) children attending arthritis youth camps in Aus-
tralia, New Zealand and Canada reported using CAM ther-
apies such as copper bracelets, dietary changes, and patent
medicines [6]. In a survey of 76 patients with diverse diag-
noses seen at the Wake Forest University rheumatology
clinic between 2001 and 2003, the most commonly
reported CAM therapies were faith healing (14%) and
massage (11%) (personal communication with Dr. Sara
Sinal, 1/9/07). Differing rates among these studies may
have been reported due to geographic differences, differ-
ences in survey questions, differences in survey popula-
tions, and changes in practice over time. Overall, little is
known about how patients' families perceive the effective-
ness and safety of CAM, home and folk remedies or, for
that matter, how they perceive mainstream therapies for
JIA. Recent advances in understanding the pathophysiol-
ogy of arthritis have broadened the medication repertoire
for treating JIA. Physicians anticipate that their patients
follow treatment recommendations, but parent's percep-
tions of these treatments will influence what the child ulti-
mately receives. Furthermore, families often talk with one
another in waiting rooms, but little is known about what
they recommend to each other. Given the variety of treat-
ments for JIA, both mainstream and CAM, it is important
to assess parental perception of therapy; to our knowl-
edge, this is the first study to address this in patients with
JIA.
This study had three aims: 1) to describe the use of specific
CAM therapies (including home remedies and folk reme-
dies), in the context of their use of conventional therapies;
2) to assess parents' perceptions of the helpfulness and
side effects of all therapies the patient had used recently
and 3) to describe what therapies parents would recom-
mend to other families of JIA patients. We were interested
in these questions to better counsel patients and to under-
stand which CAM therapies might be most acceptable for
future study in this population. The survey was not con-
ducted as hypothesis-testing study.
Methods
We surveyed parents of JIA patients between June 1 and
July 31, 2007. Parents were eligible if they had a child
diagnosed with JIA using the International League of
Associations for Rheumatology classification [7] who had
been seen within the previous six months by the only
pediatric rheumatologist (KRS) at Brenner Children's
Hospital. This clinic cares for children from birth through
21 years of age. The patient's medical records were
reviewed by a research assistant supervised by the rheuma-
tologist to determine eligibility, patients' ages and diag-
nostic category. Parents were recruited through a letter
sent by the rheumatologist and the director of the Pro-
gram for Holistic and Integrative Medicine (KJK). The let-
ter included the survey questionnaire, a stamped self-
addressed return envelope, $2 cash, and an offer of $10
gift certificate for completion and return of the survey
questionnaire. The letter asked parents to complete the
surveys with the patients' assistance to enhance accuracy.
Questionnaire
The questionnaire included demographic questions, a sin-
gle question on the patient's overall health status (excel-
lent/good/fair/poor), and information about the duration
and type of the child's illness. Demographic characteris-
tics included the patient's age, gender, race/ethnicity,
maternal education and parents marital status and type of
JIA. We also asked about patients' other illnesses. Ques-
tionnaires were sent to the patients' parents and were gen-
erally completed by patients' mothers (98%) with input
from the patients themselves.
We assessed patients' use of different therapies with an
extensive list of conventional therapies such as prescrip-
tion and non-prescription medications, assistive devices,
physical therapy interventions and home care (extra rest,
therapeutic exercise); and complementary therapies (e.g.,
specific supplements, massage, magnets, stress manage-
ment tools, spiritual healing, etc.); and professional care
provided by chiropractors, acupuncturists, massage thera-
pists and naturopathic clinicians. These therapies were
compiled from three primary sources: previous research
on CAM use in rheumatology and pediatrics; local experi-
ence in pediatrics; and statewide experience among older
adults with arthritis [8]. The list was pilot tested in parents
of two adolescents with JIA who were not part of this
study; no revisions were suggested. For each therapy,BMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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questions addressed a) whether the therapy had been
used in the past 30 days (yes/no); for those who had used
it, how helpful it was (0 = not helpful; 1 = somewhat; 2 =
moderately; 3 = very helpful); side effects (0 = none; 1=
mild; 2= moderate; 3 = severe); and whether the parent
would recommend it to other patients with JIA (Yes, No
or Not Sure). The entire list of therapies is available from
the authors upon request.
Data management
All questionnaires were completed anonymously. Data
were entered into a secure Microsoft Access Database
which was backed up nightly. Data entry was checked by
a separate assistant and further checked for reasonable
ranges; a 25% sample was triple checked against original
paper copies to ensure accuracy.
Analysis
Data analysis focused on descriptive statistics. We calcu-
lated the proportion of children using each therapy. Next,
because some data were not normally distributed, we cal-
culated the median and mean rating of helpfulness and
side effects for each therapy. We then calculated the pro-
portion of parents who would recommend the therapy to
other patients. Only those who used the therapy were
included for the calculation of helpfulness, side effects
and recommendation. For each therapy class, the propor-
tion of children who used at least one therapy within the
class, the highest mean and median rating of helpfulness
and side effects for the class and the proportion of those
would recommend at least one therapy were calculated.
Similarly, usage, maximum helpfulness and side effects
and recommendation for 'any CAM therapy' were calcu-
lated from individual CAM therapies. We used Wilcoxon
signed-rank tests to compare each therapy class and 'any
CAM therapy' to the conventional medication class (refer-
ence). A p-value of <0.05 was considered statistically sig-
nificant. We used Stata Intercooled Version 8.2 for
statistical analysis.
Human Subjects
This study was approved by the Wake Forest University
School of Medicine Institutional Review Board.
Results
Of the 76 eligible patients, 52 (68%) parents returned
completed questionnaires after two reminders had been
sent. Of the 52 parents, 50 were mothers and two were
fathers; most (75%) respondents were married and 62%
had at least some college or a college degree. The 24
patients whose parents were non-respondents were simi-
lar to the children of respondents in terms of age 11.8 ±
3.2 years versus 10.7 ± 4.8 years; race (87% of both were
Caucasian) and gender (27% versus 19% male for
respondents).
The age range of the children was 2.7 years to 20.1 years
with a mean of 10.9 years. Patients had been diagnosed
with JIA for an average of 4.9 years and most had oligoar-
thritis (40%) or rheumatoid factor negative polyarthritis
(29%; see Table 1). Co-morbid conditions were reported
for 67% of patients, most commonly allergies (37%) and
headaches (27%). Nearly 75% of parents rated their
child's health as excellent or very good; this is representa-
tive of the population seen in the pediatric rheumatology
clinic.
Conventional Therapies used
The most common therapies used in the 30 days prior to
the survey are listed in Table 2. Medications were used by
45 (88%) of patients, most commonly methotrexate
(42%), acetaminophen (38%), and/or naproxen (33%);
none used hydroxychloroquine and only two used sul-
fasalazine (data not shown). Eighty-eight percent used at
least one medication. Most (69%) children engaged in
therapeutic exercise (most commonly stretching and
swimming); 67% used heat or cold for painful joints; 54%
reported getting extra rest; and 20% of patients required
wheelchair, orthotics, braces or splints. No patients
reported using a cane or ultrasound therapy.
Complementary therapies used
Complementary therapies were used by 92% of patients
(see Table 2). For example, 54% of patients received mas-
sage for painful joints. Unlike the studies in adults [9-11],
no parent reported using topical capsaicin, DMSO, olive
oil, peanut oil, turpentine, vinegar, WD40® or TigerBalm®
for their child; however, three parents reported using
Vicks VapoRub® on patients' joints.
Dietary supplements and dietary changes were among the
most commonly used complementary remedies. For
example, 40% received multivitamins and 19% received
vitamin C. Fewer received vitamin D (13%), omega three
fatty acids/fish oil supplements (6%) or glucosamine
(4%). Unlike surveys of adult arthritis patients, no parent
reported giving their child bromelain, flax seed oil,
gamma linolenic acid, evening primrose oil, quercetin, S-
adenosylmethionine, turmeric or curcumin. Many (35%)
parents reported that they avoided giving their child spe-
cific foods that they thought might aggravate their child's
pain. For example, 35% avoided dairy and 27% avoided
meat; between 10% and 20% avoided oranges, fish/shell-
fish, or wheat/gluten. Fewer than 10% avoided tomatoes,
peppers, eggplant or soy.
Stress management techniques and spiritual healing were
also commonly used, but professionally provided CAM
therapies were not. Between 12% and 25% of parents
used music, support groups or relaxation tapes or CDs to
help their child's symptoms. Slightly more than one quar-BMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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ter reported using spiritual healing. Fewer than 3% used
guided imagery, meditation, progressive relaxation, aro-
matherapy, yoga, tai chi, homeopathy or magnets; only
one parent each reported trying a professional counselor
or Healing Touch. No parents reported using copper
bracelets, biofeedback or hypnosis to help with the child's
pain or other symptoms. No parent reported taking their
child to an acupuncturist, chiropractor, herbalist, profes-
sional massage therapist, naturopathic clinician, or osteo-
pathic physician in the 30 days prior to the survey.
Perceived helpfulness and side effects
The therapies that were used most often were generally
rated as the most helpful. Among medications, meth-
otrexate, naproxen, biological agents, and prescription
anti-inflammatory medications were rated as most help-
ful (median score of 3). Other conventional recommen-
dations that had median scores ≥ 2.5 included
corticosteroids, diclofenac, wheel chairs, orthotics, hot
baths, and swimming. Although acetaminophen and ibu-
profen were commonly used, they were reportedly less
effective; ice was the least effective of the conventionally
recommended therapies. Conventional therapies had a
median side effect score of 1; the only conventional ther-
apies for which parents reported notable side effects were
corticosteroids, wheel chairs and splints. Details on what
parents perceived as side effects were not collected.
Complementary remedies that were rated as most effec-
tive (median score of 3) were support groups, spiritual
healing, rubbing Vicks' VapoRub® on the joints, and vita-
min D; those with a median score ≥ 2 included dietary
supplements (multivitamins, vitamin C, fish oil and glu-
cosamine); relaxation tape or CD and music. All comple-
mentary therapies had a median side effect score of 0.
The mean perceived helpfulness of the conventional med-
ication class was significantly higher than that of heat or
cold (p = 0.01), therapeutic exercise (p = 0.008), extra
sleep or rest (p < 0.0006), vitamins and other dairy sup-
plements (p = 0.03), and avoiding foods (p = 0.03; see
Table 2). However, when comparing perceived helpful-
ness of the conventional medication class to 'any CAM
therapy,' there was no significant difference (p = 0.29).
The mean perceived side effects of the conventional med-
ication class was significantly higher than that of physical
therapy (p = 0.04), heat or cold (p = 0.0001), extra sleep
or rest (p = 0.002), massage (p = 0.003), vitamins and
other dietary supplements (p = 0.002), avoiding foods (p
= 0.03), and spiritual healing (p = 0.004). Perceived side
Table 1: Sample characteristics
Characteristic N= 52 (100%)
Child's Age in years – median (mean ± sd) 10.8 (10.9 ± 4.7)
Child Gender: Male – N (%) 10 (19)
Child's race/ethnicity – N (%)
Caucasian, not Hispanic 45 (87)
African American, not Hispanic 3 (6)
Hispanic 4 (8)
JIA Duration in years – median (mean ± sd) 3.3 (4.9 ± 4.0)
JIA Subtype N (%)
Oligoarthritis 21 (40)
Rheumatoid-factor negative polyarthritis 15 (29)
Systemic arthritis 6 (12)
Enthesitis-related arthritis 6 (12)
Other 4 (8)
Co-morbidity: median (mean ± sd) number of problems 1 (1.4 ± 1.6)
None N (%) 17 (33)
Allergies N (%) 19 (37)
Headaches N (%) 14 (27)
Abdominal Pain N (%) 7 (14)
Constipation or Diarrhea N (%) 6 (12)
Acne N (%) 6 (12)
Other, includes depression, scoliosis, eczema, asthma, GERD N (%) 10 (20)
Overall health, parental rating – N (%)
Excellent 13 (25)
Very Good 25 (48)
Fair 14 (27)
Poor 0BMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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Table 2: Perceptions and recommendations about therapies used by three or more patients in past 30 days (N = 52)
Therapy Used in past 30 days n 
(%)
Helped Median (Mean) Side effects Median (Mean) Recommended N (% of 
those who made 
recommendations)
Medications 0 = not helpful; 3 = very 
helpful
P value* 0 = none; 3 = severe P value†
Medications (Any) 45 (88) 3 (2.7) Reference 1 (1) Reference 40 (87)
Methotrexate 22 (42) 3 (2.5) 0 (0.7) 17 (77)
Acetaminophen 20 (38) 2 (1.6) 0 (0.1) 15 (75)
Naproxen 17 (33) 3 (2.4) 0 (0.6) 12 (80)
Ibuprofen (any brand) 14 (27) 2 (1.6) 0 (0.2) 10 (77)
Biologics: Etanercept, 
Adalimumab, or Infliximab
10 (19) 3 (3.0) 0 (0.2) 8 (80)
Celebrex®, Mobic®, 
Relafen®, or Talmentin®
7 (13) 3.0 (2.1) 0 (0.6) 4 (57)
Corticosteroids (prednisone 
or prednisolone)
8 (15) 2.5 (2.1) 1 (1.4) 2 (29)
Diclofenac (Voltaren®) 6 (12) 2.5 (2.2) 0 (0.6) 4 (80)
Physical Therapy 12 (23) 2 (1.9) 0.09 0 (0.3) 0.04 11 (92)
Heat or cold (Any) 35 (67) 2 (2.2) 0.01 0 (0.23) 0.0001 31 (94)
Hot baths or hot tub (to 
ease pain)
28 (56) 2.5 (2.2) 0 (0.1) 27 (100)
Ice packs 14 (27) 1 (1.2) 0 (0.6) 9 (64)
Hot packs 13 (25) 2 (2) 0 (0.1) 11 (85)
Assistive Devices (Any) 10 (20) 2.5 (2.2) 0.23 0 (0.7) 0.35 9 (90)
Wheelchair 4 (8) 3 (2.8) 1 (1.3) 3 (75)
Orthotics (shoe inserts) 4 (8) 3 (2.5) 0 4 (100)
Braces 4 (8) 1.5 (1.8) 0.5 (0.5) 2 (50)
Splints 3 (6) 2 (1.7) 1 (1) 2 (67)
Therapeutic exercise (Any) 36 (69) 1 (0.69) 0.008 0 (0.48) 0.06 32 (89)
Stretching 29 (56) 2 (2) 0 (0.4) 24 (86)
Swimming 27 (52) 3 (2.2) 0 (0.3) 23 (92)
Other: aerobics, exercise 
ball, cheerleading, biking
6 (12) 3 (2.5) 0 (0.4) 5 (83)
Extra sleep or rest 28 (54) 2 (2) 0.0006 0 (0.2) 0.002 25 (89)
ANY CAM, including 
HOME OR FOLK 
REMEDY LISTED 
BELOW
48 (92) 3 (2.5) 0.29 0 (0.29) 0.002 41 (91)
Massage by self or family 
member
28 (54) 2 (1.9) 0.03 0 (0.3) 0.003 22 (81)
Salves/ointments : Vicks 
Vapo-Rub
3 (6) 2 0.16 0 (0.7) 0.32 3 (100)
Vitamins and other 
Dietary supplements 
(ANY)
28 (54) 2 (1.9) 0.03 0 (0.12) 0.002 22 (88)
Multivitamins 21 (40) 2 (1.9) 0 (0.2) 15 (83)
Vitamin C 10 (19) 2.5 (2.1) 0 9 (100)
Vitamin D 7 (13) 3 (2.3) 0 (0.3) 7 (100)
Fish oil or omega 3 fatty 
acids
3 (6) 2 (2) 0 2 (100)
Glucosamine 2 (4) 2 (2) 0 2 (100)
Avoiding foods that 
worsen pain
18 (35) 2 (1.6) 0.03 0 (0.07) 0.03 13 (18)
Dairy (milk) 18 (35) 1.5 (1.4) 0 (0.1) 12 (67)
Meat 14 (27) 1 (1.3) 0 5 (36)
Oranges 9 (17) 1 (1.3) 0 6 (67)
Seafood/fish 9 (17) 1 (1.2) 0 5 (56)
Wheat/gluten 5 (10) 0.5 (0.8) 0 1 (20)
Tomatoes, peppers, 
eggplant
4 (8) 0.5 (0.8) 0 2 (50)
Soy 1 (2) 1 (1) 0 1 (100)
Stress management 17 (33) 3 (2.5) 0.13 0 - 14 (82)
Music 12 (23) 2.5 (2.3) 0 9 (75)
Support Groups 6 (12) 3 (2.8) 0 5 (83)
Relaxation tape or CD 6 (12) 2.5 (2.5) 0 4 (67)
Spiritual Healing (Prayer) 14 (27) 3 (2.6) 0.69 0 (0.1) 0.004 13 (93)
* p values for helpfulness for each therapy are calculated with medications (any) as the reference.
† p values for side effects for each therapy are calculated with medications (any) as the referenceBMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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effects of conventional medication was significantly
higher than 'any CAM therapy' (p = 0.002).
Parental recommendations
Parents frequently reported that they would recommend
specific therapies to other parents of children with JIA;
these recommendations generally mirrored the therapies'
perceived helpfulness and side effect profile (see Table 2).
For example, the therapy most commonly recommended
to other parents was hot baths (N = 27), followed by extra
rest (N = 25), stretching (N = 24) and swimming (N = 23).
Methotrexate and non-prescription analgesics were rec-
ommended by most patients who used them. Fewer par-
ents recommended avoiding therapies. For example, three
parents each recommended avoiding acetaminophen and
ice packs (not effective); and three recommended avoid-
ing corticosteroids and prescription anti-inflammatory
medications (side effects). No parents recommended
avoiding any assistive devices, exercise, rest, joint rubs,
individual vitamins or supplements, dietary changes,
stress management, homeopathy, aromatherapy or Heal-
ing Touch. At least one therapy in the conventional med-
ication class and 'any CAM therapy' class was
recommended by 87% and 91% respectively among those
who used them.
Discussion
This study builds on previous research on CAM use
among JIA patients internationally and adult arthritis
patients in North Carolina. It extends previous findings in
two ways: first, by providing a benchmark of mainstream
therapies, and second by providing parents' perspectives
on the helpfulness, side effects and recommendations
about these therapies. Unlike earlier studies, it focuses on
parental perceptions of therapies rather than demo-
graphic risk factors for using CAM or for poor adherence
to conventional recommendations [4,5,12,1]. It provides
rich guidance for clinicians in discussing a variety of CAM
therapies in addition to medications, physical therapy
and assistive devices. It also provides essential informa-
tion for researchers interested in evaluating the effective-
ness of specific CAM therapies. Prior to embarking on
randomized, double-blind placebo controlled (RDBPC)
trials to scientifically evaluate CAM therapy effectiveness,
it is beneficial to have a benchmark. This study suggests
that vitamin D, vitamin C, fish oil and glucosamine were
CAM therapies rated by parents as effective, and these
therapies may be pursued in future RDBPC trials.
As expected among patients seen in a tertiary care, pediat-
ric rheumatology clinic, most patients in this study used
medications [14]; they also frequently used conventional
therapies such as physical therapy, heat, rest, and exercise
[15]. Bone health is critical to address in managing chil-
dren with JIA; traditionally, calcium and vitamin D have
been regarded as CAM therapy, yet inquiring about cal-
cium and vitamin D intake in these patients is routine. As
the distinction between mainstream and CAM therapies
has become somewhat blurred, in this study, parents were
asked about specific therapies in groups (such as medica-
tions, dietary changes, stress management) rather than as
mainstream versus CAM [8]. Likewise, clinicians may find
it more useful and revealing to ask patients about their use
of specific therapies used rather than asking about CAM
therapies per se.
Variations in CAM use
Although this study does not specifically address changes
in use of therapies over time, based on previous reports, it
appears that there may be variability affected by time,
geography, ethnicity, and by the way in which these ther-
apies are defined. Such changes are reflected in the use of
copper bracelets; copper bracelets were the most com-
monly used unconventional remedy in a survey of chil-
dren attending arthritis youth camps in Australia, New
Zealand and Canada in 1990, but none of the parents in
our 2007 study reported using them for their children [6].
Similarly, aquatic therapy has been recently reported for
patients with JIA, but was not specifically included in ear-
lier surveys [15].
Geographic variations are exemplified by Feldman's 2004
study of CAM use in Canadian JIA patients among whom
naturopathy and acupuncture were the most commonly
used CAM therapies, whereas these therapies were used by
none of our patients; on the other hand, spiritual healing
was common in this population and uncommon in Can-
ada. Similarly, chiropractors were used by 21% of the JIA
patients in Hagen's study in Toronto, but none of the
patients in this study. None of the Canadian patients
reported using Vick's VapoRub® on their joints; this oint-
ment was invented in North Carolina.
In a survey of Hispanic JIA patients in Chicago, the most
commonly used CAM therapies were prayer and massage
therapy, whereas in our largely Caucasian population, the
most common CAM therapies were massage, vitamins
and other supplements, avoiding foods that aggravated
symptoms and stress management techniques [16].
Multivitamins and supplemental calcium and vitamin D
have become commonplace recommendations for
patients with JIA, yet they are included as CAM therapies
in earlier surveys [5].
Similarities and differences with adults
The pediatric patients in the present study show several
similarities in the use of therapies to North Carolina
adults [9], but little similarity to adults from another
region [10] or adults nationally [11]. For example, like NCBMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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adult arthritis patients, over 80% of the JIA patients used
medications. A similar proportion of our JIA patients and
NC adults with arthritis also used rest and heat to treat
symptoms. However while only 6% of the JIA patients in
this study used salves, 18% of NC adults with arthritis
used lotions or creams, and 52% used ointments or lini-
ments. The complementary therapies addressed in the dif-
ferent studies varied. More importantly, questionnaire
items for the present study asked about therapies used in
the past 30 days, while in the other studies questionnaire
items asked about "ever", undefined current use [9,10], or
use in the past year [11].
Parental perceptions
Few studies have examined parents' perceptions about the
helpfulness or side effects of complementary or main-
stream therapies for children with chronic conditions [17-
19]. In a study of parents of children seen with attention
problems at a tertiary care center in Boston, Chan, et al.
found that 24 parents would recommend CAM therapies
such as music, dietary modifications, sensory integration
and exercise while only 8 parents would recommend
stimulant medications [20]. When asked what therapies
they would recommend other parents avoid, 7 parents
warned about prescription medications and 7 warned
about "unproved" therapies such as blue-green algae and
magnets. Many more of the parents in our study recom-
mended medications, and fewer recommended that par-
ents avoid them. Interest in CAM therapies and parental
recommendations to use them were common in both the
ADHD and JIA groups.
Patients' parents in this study reported that their medica-
tions were effective, and that simple measures such as hot
baths, rest, swimming, stretching, massage, music, guided
imagery, prayer, support groups, relaxation CDs and cer-
tain vitamins were also moderately effective and free of
significant side effects.
Interestingly, there was no significant difference in per-
ceived helpfulness of conventional medication compared
to 'any CAM' class. Our observation should be interpreted
cautiously-there were more individual therapies included
in the 'any CAM' group, thereby increasing the likelihood
of perceived helpfulness of at least one therapy within that
group. Furthermore, recent advances in understanding the
pathophysiology of arthritis have resulted in biologic
therapies demonstrating efficacy in JIA, even in patients
refractory to methotrexate [21,22]. Non-steroidal anti-
inflammatory drugs (NSAIDs) have been used for several
years for analgesia, but they do not modify disease pro-
gression.
Although there were more therapies for 'any CAM,' per-
ceived side effects of the conventional medication class
was significantly higher. This is not surprising, as all med-
ications are associated with adverse effects, while several
of the therapies in CAM have virtually no side effects.
Dietary changes, such as restricting certain foods, were
more common than expected and offer an intriguing area
for future research. Dietary restrictions are also important
for clinicians to address, particularly given the increased
risk of osteoporosis in the JIA population [23,24]; for
patients who choose to limit dairy intake to reduce symp-
toms, supplemental calcium, vitamin D and weight-bear-
ing exercise may be particularly important in reducing the
long-term risks of osteoporosis. Furthermore, parental
perceptions about the helpfulness of vitamin D in this
study support other clinical observations that vitamin D
inhibits inflammatory processes and suppresses the
enhanced activity of immune cells that take part in the
autoimmune reaction [25]. The possibility that vitamin D
might offer acute benefits on inflammatory symptoms as
well as longer-term benefits on bone health combined
with families' interest in this therapy suggest that this is a
fertile area for future research.
Limitations
This study had several limitations and strengths. Although
it was conducted in one university-based clinic, it had a
high response rate; patients in this clinic are similar demo-
graphically and in terms of disease to many others in the
US. Generalizability is limited because of geographic var-
iations in the licensing and practice of CAM clinicians; for
example, as in most of the US, naturopaths are not
licensed in NC, but they are licensed in some states, and
children in these states might be expected to visit them
[26].
Questionnaires may lead to recall bias; we attempted to
minimize this and enhance accuracy by inquiring about
therapies used in the past 30 days. This time frame is
shorter than other studies, and may have missed therapies
that had been tried and discontinued for various reasons.
We were concerned that the length of the questionnaire
would prove challenging, but completion rates were high
and the response to questions on recommendations were
consistent with the responses to questions about helpful-
ness and side effects. Although we asked parents to seek
input from their children when completing the question-
naire, we did not monitor questionnaire completion, so
we do not know the extent to which parents did so.
This study did not collect data from the rheumatologist
about treatment recommendations or determine adher-
ence; instead it focused on parental perceptions about
effectiveness and safety of therapies that had been used.
Because the survey was anonymous, we cannot correlateBMC Complementary and Alternative Medicine 2008, 8:25 http://www.biomedcentral.com/1472-6882/8/25
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parental reports about use of different therapies with
rheumatologist recommendations.
Future Research
The survey focused on the patients and includes some
demographic data about parents, but no psychological
data about parents; future studies might evaluate the
impact of parental functioning on their use of CAM ther-
apies for children with JIA. We asked parents which ther-
apies they "would recommend" to other parents, but did
not ask them how often they had actually made such rec-
ommendations; this might be an interesting question for
a future study. Since the study was exploratory in nature,
we used multiple testing without correction to compare
each therapy class with the conventional medication class.
This could have resulted in Type I error. The lack of differ-
ence seen between groups could have resulted from insuf-
ficient power. Future studies might make these
comparisons using a larger sample size and a smaller
number of commonly used therapies.
Conclusion
Pediatric patients with JIA seen in a university rheumatol-
ogy clinic frequently use complementary therapies in
addition to their medications. Even though parents
viewed some conventional medications as being more
helpful than some CAM therapies overall, the use of CAM
was perceived as being similarly helpful as conventional
medications. Use of professionally provided CAM thera-
pies is rare. Future studies of CAM therapies, particularly
those that parents feel are helpful and low in side effects,
such as vitamin D are warranted.
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